Table of Content


Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Genomics dealmaking

2.1. Introduction
2.2. Genomics partnering over the years
2.3. Most active Genomics dealmakers
2.4. Genomics partnering by deal type
2.5. Genomics partnering by therapy area
2.6. Deal terms for Genomics partnering
2.6.1 Genomics partnering headline values
2.6.2 Genomics deal upfront payments
2.6.3 Genomics deal milestone payments
2.6.4 Genomics royalty rates

Chapter 3 – Leading Genomics deals

3.1. Introduction
3.2. Top Genomics deals by value

Chapter 4 – Most active Genomics dealmakers

4.1. Introduction
4.2. Most active Genomics dealmakers
4.3. Most active Genomics partnering company profiles

Chapter 5 – Genomics contracts dealmaking directory

5.1. Introduction
5.2. Genomics contracts dealmaking directory

Chapter 6 – Genomics dealmaking by technology type

Appendices

Appendix 1 – Genomics deals by company A-Z
Appendix 2 – Genomics deals by stage of development
Appendix 3 – Genomics deals by deal type
Appendix 4 – Genomics deals by therapy area
Appendix 5 – Deal type definitions
Appendix 6 – Further Reading

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering
?
Table of figures

Figure 1: Genomics partnering since 2015
Figure 2: Active Genomics dealmaking activity sincce 2015
Figure 3: Genomics partnering by deal type since 2015
Figure 4: Genomics partnering by disease type since 2015
Figure 5: Genomics partnering by industry sector since 2015
Figure 6: Genomics deals with a headline value
Figure 7: Genomics deals with an upfront value
Figure 8: Genomics deals with a milestone value
Figure 9: Genomics deals with a royalty rate value
Figure 10: Top Genomics deals by value since 2015
Figure 11: Most active Genomics dealmakers since 2015
Figure 12: Genomics partnering by technology type since 2015